Journal of Proteome Research · 2019 · 42 citations · 38 references
Life SciencesNeurobiologyNeuroscienceMolecular NeuroscienceNeurodegenerationProteomicsCircadian Clock MechanismsNeurodegenerative DiseasesNeurodegenerative DisordersSleep PhysiologySleep-wake NeurobiologySleep-wake RegulationAlzheimer Disease NeuroprotectionCircadian ProteomicsHippocampal FunctionHippocampal Memory FunctionMolecular Clock MechanismsSleep-wake DysregulationTherapeutic Target IdentificationTransgenic Mouse Models
Sleep disturbances and memory impairment are common symptoms of Alzheimer's disease (AD). Given that the circadian clock regulates sleep, hippocampal function, and neurodegeneration, it represents a therapeutic target against AD. Casein kinase 1δ/ε (CK1δ/ε) are clock regulators and overexpressed in AD brains, making them viable targets to improve sleep and cognition. In this study, we evaluated the therapeutic potential of a small molecule CK1δ/ε inhibitor (PF-670462) in a triple transgenic mouse model of AD (3xTg-AD). Mass spectrometry-based proteomic analyses revealed that PF-670462 administration in 3xTg-AD mice reversed hippocampal proteomic alterations in several AD-related and clock-regulated pathways, including synaptic plasticity and amyloid precursor protein processing. Furthermore, PF-670462 administration rescued working memory deficits and normalized behavioral circadian rhythm disturbances in 3xTg-AD mice. Our study provides in vivo proof of concept for CK1δ/ε inhibition against AD-associated hippocampal proteomic changes, memory impairment, and circadian disturbances.
38
Triple-Transgenic Model of Alzheimer's Disease with Plaques and Tangles
Salvatore Oddo, Antonella Caccamo, Jason D. Shepherd et al. · Neuron · 2003 · 4.1K citations · Full text
MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis
Jasmine Chong, Othman Soufan, Carin Li et al. · Nucleic Acids Research · 2018 · 3.8K citations · Full text